-
Quotient Clinical Appoints Chief Commercial Officer
contractpharma
May 31, 2017
Kalim to support further expansion of global commercial footprint
-
CROS NT Appoints President of North American Ops
contractpharma
May 31, 2017
Paul has more than 25 years of experience serving customers and managing clinical trials
-
Recipharm Makes Appointment in the UK & Ireland
contractpharma
May 27, 2017
Recipharm has invested in its UK and Ireland presence with the appointment of Shabbir Mostafa to its business management team.
-
AMAG Appoints Pharmacovigilance VP
contractpharma
April 26, 2017
Simon brings more than 20 years of pharmaceutical industry experience
-
Ipsen Appoints Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer
americanpharmaceuticalreview
April 17, 2017
Ipsen has announced the appointment of Dr. Alexandre Lebeaut as Executive Vice-President, R&D, and Chief Scientific Officer, effective immediately.
-
Repros Names Dillaha its Permanent President and CEO
americanpharmaceuticalreview
April 12, 2017
Repros Therapeutics Inc.® has announced that the Company’s Board of Directors has appointed Larry Dillaha, M.D., the President and Chief Executive Officer of the Company, effective immediately.
-
Allergan Names Senior Vice President of Global Investor Relations & Strategy
americanpharmaceuticalreview
April 10, 2017
Allergan has announced that Daphne Karydas will join the Company as Senior Vice President of Global Investor Relations and Strategy, effective April 17, 2017.
-
Piramal Pharma Solutions Appoints CCO
contractpharma
March 21, 2017
Needleman responsible for driving all global business development activities
-
Arena Pharmaceuticals Appoints Executive Vice President, Research and Development and Chief Medical
americanpharmaceuticalreview
March 21, 2017
Arena Pharmaceuticals, Inc. has announced the appointment of Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Klassen will report to Amit Munshi, Arena's President and Chief Executive O
-
BMS appoints Dr Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer
cphi-online
March 10, 2017
He succeeds Dr Francis Cuss, 62, who will retire from the company.